Workshop on implementing package of essential NCD interventions (PEN) for primary health care in eastern Europe and central Asia
24–25 March 2017, Helsinki, Finland
This workshop aims to bring together 13 countries to discuss implementing essential noncommunicable disease (NCD) interventions in primary care within eastern Europe and central Asia. It will provide opportunities for sharing experience and updates on progress since the last meeting, and for further exploring common topics of interest such as quality systems, training and education, and monitoring and evaluation of impact.
A particular theme will be how broader community and patient initiatives might support NCD prevention and treatment in clinical settings, and delegates will learn from the experience of North Karelia and Finland. The global HEARTS initiative will also be introduced. The workshop’s programme will benefit from the expertise of WHO collaborating centres and international experts, and is designed to be interactive.
Achieving the global target of a 25% reduction in premature mortality from NCDs by 2025 requires a mixture of population-wide and individual interventions. Regarding individual interventions in primary health care, other relevant voluntary global targets are those for reducing the prevalence of raised blood pressure by 25% (target 6), and ensuring that at least 50% of people at high cardiovascular risk receive appropriate drug therapy and counselling to prevent heart attacks and strokes (target 8).
Within the WHO European Region, a number of countries have embarked on implementation of the WHO PEN or its equivalent in primary care, and many share the aim of strengthening cardio-metabolic risk assessment and management in particular. A first meeting of the early implementers, held in Kyrgyzstan in October 2015, identified issues of common interest and a willingness to share experience, provide peer support and develop a community of practice. A second meeting, held in Uzbekistan in May 2016, focused on various topics of relevance to clinical guideline implementation such as training, comprehensive quality systems, monitoring and evaluation, and community initiatives to support interventions within clinical settings.
Participation is by invitation only.
For more information about the workshop, please contact Dr Jill Farrington, Coordinator, Noncommunicable Conditions and Senior Technical Officer, Cardiovascular Diseases and Diabetes, at: email@example.com.
The meeting is organized by the Regional Office in the context of the Project on the Prevention and Control of NCDs, financed by the Ministry of Health of the Russian Federation.